Roxadustat (CAS 808118-40-3) Erythropoiesis-Stimulating API

Roxadustat (CAS 808118-40-3) is a cutting-edge erythropoiesis-stimulating API, specifically designed to regulate hypoxia-inducible factor (HIF) pathways. Crafted with stringent quality control, it features exceptional molecular integrity and high bioavailability, ensuring reliable efficacy in pharmaceutical formulations. As a novel HIF prolyl hydroxylase inhibitor, it effectively stimulates red blood cell production, addressing the root cause of anemia.

This pharmaceutical-grade API meets global quality standards, making it ideal for drug manufacturers, biotech companies, and research institutions focused on hematology therapeutics. It offers consistent batch performance, excellent formulation compatibility, and clinically validated effectiveness. For those seeking a innovative, high-quality raw material to develop anemia treatments—without relying on traditional erythropoietin—Roxadustat delivers unparalleled value as a cost-effective and reliable solution.